2010

• HPV prevalence and persistence in a cohort of HIV positive women in Ireland
  Mc Inerney J, H Keegan, L Pilkington, A Loy, C White, S Delamere, F Karlsen O Sheils, CM Martin, F Mulcahy and JJ O' Leary
• A novel expression biomarker set has high accuracy to predict CIN1+ lesions using routine cervical cytology specimens
  Jeney C, Mózes J, Varga N, Benczik M, Kovács A, Kaltenecker B, Szenthe B, Takács T, Kurucz M, Lukács A, Keegan H, Pilkington L, Spillane CD, Martin CM, J. O'Leary JJ
• The NSAID Sulindac inhibits proliferation and induces apoptosis in cervical cancer cell lines
  Spillane CD, White C, Linder K, McEligott T, Kehoe L, Sheils O, Martin CM, O'Leary JJ
• Significance of HPV mRNA testing and cigarette smoking in risk assessment for high grade cervical disease
  White C, Ruttle C, Pilkington L, Flannelly G, O'Leary JJ, Martin CM
• Comparison of HPV DNA detection technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population
  O'Leary, JJ Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM
• Transcriptome analysis of oncogene silenced HPV 16 positive carcinoma cells
  Spillane CD,Kehoe L, Sheils O, Martin CM, O'Leary JJ
• NSAID, sulindac, inhibits proliferation and induces apoptosis in cervical cancer cells
  CD Spillane, L Kehoe, O Sheils, CM Martin and JJ O'Leary
• Lab-on-a-Chip: The Future of Cervical Pre-Cancer Diagnostics
  H Keegan, T Baier, T Hansen-Hagge, F Karlsen, A Gullicksen, P Gronn, L Solli, M Mielnik, L Furuberg, P Koltay, L Riegger, N Bolger, JJ O'Leary, CM Martin
• Human Papillomavirus DNA and mRNA Prevalence and Persistence in a Cohort of Human Immunodeficency Virus Positive Women in Ireland
  J Mc Inerney, H Keegan, L Pilkington, O Sheils, CM Martin, A Loy, S Delamere, M Barrett, M Griffin, F Lyons, F Mulcahy, JJ O'Leary
• Raman Spectroscopy: A Novel Tool for Cervical Cancer Screening
  KM Ostrowska, A Malkin, HJ Byrne, C Martin, JJ O'Leary, FM Lyng
• Comparison of HPV detection technologies; Hybrid Capture 2 (Qiagen), full-spectrum HPV (Genoid), Genoid Molecular Beacon Real-Time HPV assay with genotyping by Linear Array (Roche) and Genoid HPV Elisa Genotyping Assay in an Irish colposcopy population
  Keegan H, Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A, Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM
• Comparison of HPV DNA detection technologies; Hybrid Capture 2 (Qiagen), Cervista™ (Hologic UK Ltd) in a Northern Irish screening population
  Keegan H, Pilkington L, Jamieson J, Wilson RT, Carson J, Martin CM, O'Leary JJ
• Human papillomavirus DNA and mRNA prevalence and persistence in human immunodeficency virus positive women
  Mc Inerney J, Keegan H, Pilkington, L, Sheils O, Martin C.M., Loy A, Delamere S, Barrett M, Griffin M, Lyons F, Mulcahy F, O'Leary JJ. 
• HPV infection and vaccination: levels of knowledge and attitudes among primary care physicians
  Murphy JC, Sharp L, Carsin A-E, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Investigation of the p16[INK4A] Pathway
  L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.
• Lab-on-a-Chip: The Future of Cervical Pre-Cancer Diagnostics
  H Keegan, T Baier, T Hansen-Hagge, F Karlsen, A Gullicksen, P Gronn, L Solli, M Mielnik, L Furuberg, P Koltay, L Riegger, N Bolger, JJ O'Leary, CM Martin.
• miRNA Profiling in Cervical Cancer
  L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.
• miRNA Profiling in Cervical Cancer
  L Kehoe, CD Spillane, M Gallagher, O Sheils, C Martin, JJ O'Leary.
• Human Papillomavirus DNA and mRNA Prevalence and Persistence in a Cohort of Human Immunodeficency Virus Positive Women in Ireland
  J Mc Inerney, H Keegan, L Pilkington, O Sheils, CM Martin, A Loy, S Delamere, M Barrett, M Griffin, F Lyons, F Mulcahy, JJ O'Leary.
• Comparison of HPV DNA detetion technologies: Hybrid capture II (Qiagen), Cervista™ HPV HR (Hologic UK Ltd) in a Northern Irish Screening Population
  Keegan H, Pilkington L, Jamison J, Wilson R, Carson J, Martin CM, O'Leary JJ.